Pre-Open Stock Movers 08/24: (NNBR) (XBIT) (TSLA) Higher; (ONTX) (MWK) Lower (more...)
- Wall Street extends slide on rising inflation fears
- Fed Has Already Changed its Policy Due to Inflation, Market Gambling Fears - Dick Bove
- U.S. consumer prices post largest gain since 2009 as inflation ramps up
- Bill Ackman said has been working on a transaction for Pershing Square Tontine (PSTH) for months
- FuboTV (FUBO) Surges After Crushing Views on New Subscribers Adds, Analysts Positive
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Onconova Therapeutics, Inc. (NASDAQ: ONTX) 72.3% LOWER; announced that INSPIRE, the companys pivotal Phase 3 study assessing the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients, did not meet its primary endpoint of improved survival.
Liminal BioSciences (NASDAQ: LMNL) 60.4% HIGHER; FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID-19 Treatment
Sonnet BioTherapeutics (NASDAQ: SONN) 54.8% HIGHER; FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID-19 Treatment
ADMA Biologics (NASDAQ: ADMA) 37.3% HIGHER; FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID-19 Treatment
NN, Inc. (NASDAQ: NNBR) 25.8% HIGHER; announced a definitive agreement under which NN, Inc.'s Life Sciences division will be purchased by affiliates of American Securities LLC for the purpose of being combined with its portfolio company, MW Industries, a provider of highly engineered springs, specialty fasteners, bellows and other precision components.
ThermoGenesis Holdings, Inc. (NASDAQ: THMO) 20% HIGHER; FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID-19 Treatment
Mohawk Group Holdings, Inc. (NASDAQ: MWK) 17.5% LOWER; announced the pricing of its public offering of 3,357,140 shares of its common stock at a price to the public of $7.00 per share. Gross proceeds, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $23.5 million. Mohawk currently intends to use the net proceeds from the offering to acquire, invest in or license complimentary products, technologies or businesses, including the acquisition of a consumer products business with which Mohawk has entered into a definitive purchase agreement. The completion of the acquisition is subject to obtaining certain required third party approvals and the satisfaction of customary closing conditions. If Mohawk does not complete the acquisition, Mohawk may use a portion of the net proceeds for general corporate purposes, including working capital, operating expenses and capital expenditures. In addition, Mohawk has granted the underwriter a 30-day option to purchase up to 503,571 additional shares of its common stock at the public offering price, less the underwriting discounts and commissions. The offering is expected to close on or about August 26, 2020 subject to satisfaction of customary closing conditions.
iBio, Inc. (NYSE: IBIO) 16.6% HIGHER; FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID-19 Treatment
XBiotech Inc. (NASDAQ: XBIT) 16% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for COVID-19 Convalescent Plasma (CCP) as a COVID-19 treatment, opening the door for XBiotech’s antibody screening technology used to identify CCP. XBiotech collaborated with BioBridge Global to develop a test to accurately detect human antibodies present in patient blood that specifically attack the COVID-19 virus. BioBridge Global, which provides blood products to hospitals through its subsidiary, the South Texas Blood & Tissue Center, is using XBiotech’s test to identify human bloods from patients that have recovered from COVID-19—so called convalescent plasma. BioBridge utilizes the convalescent plasma to produce naturally immune blood products as treatment for patients hospitalized with the virus.
Cerus (NASDAQ: CERS) 15.3% HIGHER; FDA Issues Emergency Use Authorization for Convalescent Plasma as Potential Promising COVID-19 Treatment
Rocket Companies, Inc. (NYSE: RKT) 11.6% HIGHER; sees continued momentum
Fastly Inc. (NYSE: FSLY) 6% HIGHER; Raymond James upgraded from Market Perform to Outperform with a price target of $100.00.
Tesla, Inc. (NASDAQ: TSLA) 3.6% HIGHER; Wedbush raised his "bull case" price target on Tesla from $2,500 to $3,500 on the back of the strong growth in China
Apple (NASDAQ: AAPL) 3% HIGHER; Morgan Stanley raised the price target on to a 'Street High' $520.00 (from $431.00) while maintaining an Overweight rating.
Facebook, Inc. (NASDAQ: FB) 1.6% HIGHER; price target raised at Citi and Jefferies
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pre-Open Stock Movers 05/11: (FOE) (CERC) (UFS) Higher; (JMIA) (RXT) (SPCE) Lower (more...)
- CSX Corp. (CSX) to Acquire Quality Carriers, Inc.
- Pre-Open Stock Movers 05/12: (LHDX) (UPST) (EYES) Higher; (ARRY) (CURI) (LMND) Lower (more...)
Create E-mail Alert Related CategoriesSpecial Reports
Related EntitiesCiti, Raymond James, Morgan Stanley, Jefferies & Co, Tesla, Pre-Open Losers, Pre-Open Winners, Definitive Agreement, Pre Market Movers, FDA
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!